Category: Pharmaceuticals - Page 2

Manufacturing Cost Analysis: Why Generic Drugs Are So Much Cheaper
Dec 16 2025 Ryan Gregory

Manufacturing Cost Analysis: Why Generic Drugs Are So Much Cheaper

Generic drugs cost 60-95% less than brand-name versions because they skip R&D, avoid marketing, and benefit from massive scale and competition. Learn how manufacturing efficiency drives down prices without sacrificing safety or effectiveness.

Detail
Environmental Monitoring: Testing Facilities for Contamination in Manufacturing
Dec 9 2025 Charlie Hemphrey

Environmental Monitoring: Testing Facilities for Contamination in Manufacturing

Environmental monitoring detects contamination in manufacturing facilities through air, surface, and water testing. Learn how zone classification, sampling methods, and real-time data help prevent product recalls and ensure consumer safety.

Detail
Documentation Requirements for Record-Keeping in Manufacturing: What You Must Do to Stay Compliant
Dec 6 2025 Charlie Hemphrey

Documentation Requirements for Record-Keeping in Manufacturing: What You Must Do to Stay Compliant

Learn the essential documentation requirements for manufacturing under GMP standards. Understand what records to keep, how to avoid costly compliance failures, and what regulators are looking for in 2025.

Detail
GMP for Generics: FDA Requirements for Manufacturing Generic Drugs
Nov 24 2025 Charlie Hemphrey

GMP for Generics: FDA Requirements for Manufacturing Generic Drugs

FDA's CGMP requirements ensure generic drugs are as safe and effective as brand-name versions. Learn the exact rules manufacturers must follow, common violations, and how compliance keeps millions of prescriptions safe.

Detail
Manufacturing Deficiencies: Common Quality Issues Found by FDA in 2025
Nov 22 2025 Charlie Hemphrey

Manufacturing Deficiencies: Common Quality Issues Found by FDA in 2025

The FDA is cracking down on manufacturing quality failures in 2025, with rising warnings for aseptic breaches, data falsification, and poor material controls. Learn the top issues and what companies must do to avoid being banned from the U.S. market.

Detail
FDA Inspection of Generic Manufacturing Facilities: What to Expect in 2025
Nov 20 2025 Ryan Gregory

FDA Inspection of Generic Manufacturing Facilities: What to Expect in 2025

Understand what happens during an FDA inspection of a generic drug manufacturing facility, including the six-system review, Pre-Approval Inspections, FDA 483 observations, and how to prepare for compliance in 2025.

Detail
The 80-125% Rule: Understanding Bioequivalence Confidence Intervals in Generic Drugs
Nov 17 2025 Ryan Gregory

The 80-125% Rule: Understanding Bioequivalence Confidence Intervals in Generic Drugs

The 80-125% rule ensures generic drugs are absorbed similarly to brand-name versions. It's based on pharmacokinetic data, not active ingredient amounts, and is used globally to approve safe, affordable generics.

Detail
The Science Behind Fenticonazole: A Deeper Look
Apr 30 2023 Ryan Gregory

The Science Behind Fenticonazole: A Deeper Look

As a blogger, I recently delved into the fascinating world of Fenticonazole, aiming to understand the science behind this powerful antifungal agent. Through my research, I discovered that Fenticonazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, ultimately leading to their destruction. Not only is it effective against a wide range of fungal infections, but it also boasts minimal side effects and low toxicity. Furthermore, Fenticonazole's unique dual action as both a fungicide and an anti-inflammatory gives it an edge over other antifungal treatments. Overall, Fenticonazole's impressive efficacy and safety profile make it a promising option for those battling fungal infections.

Detail